Florida Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695K Sell
2,760
-225
-8% -$48.4K 0.12% 172
2026
Q1
$649K Buy
2,985
+147
+5% +$32.6K 0.16% 139
2025
Q4
$645K Buy
2,838
+673
+31% +$153K 0.18% 125
2025
Q3
$501K Sell
2,165
-881
-29% -$179K 0.15% 145
2025
Q2
$566K Buy
3,046
+273
+10% +$50.7K 0.19% 124
2025
Q1
$579K Sell
2,773
-198
-7% -$38.5K 0.23% 93
2024
Q4
$528K Buy
2,971
+971
+49% +$179K 0.24% 86
2024
Q3
$395K Buy
2,000
+283
+16% +$52.8K 0.2% 96
2024
Q2
$294K Buy
1,717
+195
+13% +$32.3K 0.18% 99
2024
Q1
$277K Sell
1,522
-145
-9% -$25K 0.2% 89
2023
Q4
$258K Buy
+1,667
New +$243K 0.24% 88

Other funds holding ABBV

Florida Financial Advisors's ABBV Position: Q2 2026 in Review

Florida Financial Advisors reduced its AbbVie (ABBV) stake by 7.5% in Q2 2026, selling an estimated $48.4K and leaving 2,760 shares worth $695K. The position accounts for 0.12% of the portfolio, ranked #172.

Florida Financial Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Florida Financial Advisors held 2,760 shares of AbbVie worth $695K as of Q2 2026.
  • Florida Financial Advisors sold 225 AbbVie shares in Q2 2026, an estimated $48.4K.
  • AbbVie made up 0.12% of Florida Financial Advisors's portfolio in Q2 2026, its #172 holding.
  • Florida Financial Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Florida Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.